Arnolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 98HS077RUP, chemically known as 2-butanol, 3-amino-1-(4-(2-methoxyethyl)phenoxy)-3-methyl- but generally known as arnolol, which bears US NIH Compound Identifier 65653. European Medicines Agency schedules Arnolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05565MIG. The term ARNOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). ARNOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule arnolol under HS 29221980 and SITC 51461. As of Q4 2014, ARNOLOL remains the US FDA Preferred Term for this commodity. Arnolol bears US NLM identifiers UMLS ID C0641873 and NCI Concept Code C73015. SMILES: OC(C(N)(C)C)COC1CCC(CCOC)CC1.